Comera Life Sciences Holdings, Inc.
CMRADelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001907685
Comera Life Sciences Holdings, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 14 institutions reported holding it in 13F filings for Q3 2023, worth $194.1K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Comera Life Sciences Holdings, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +3 vs. Q2 2023
- Shares held
- 1.04M
- +512.5K (+97.0%) vs. Q2 2023
- Total value
- $194.1K
- +$90.9K (+88.1%) vs. Q2 2023
- New holders
- 3
- 2 more added
- Sold out
- 0
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 14 | $194.1K |
| Q2 2023 | 11 | $103.2K |
| Q1 2023 | 11 | $189.8K |
| Q4 2022 | 12 | $642.8K |
| Q3 2022 | 16 | $940.8K |
| Q2 2022 | 10 | $710.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Comera Life Sciences Holdings, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CI Private Wealth, LLC | 493,692 | $123.4K | 0.00% | +493,692 | New |
| Geode Capital Management, LLC | 70,212 | $22.4K | 0.00% | +10,204+17.0% | Added |
| HighTower Advisors, LLC | 47,600 | $14.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 44,098 | $12.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 29,600 | $9.44K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 17,458 | $5.57K | 0.00% | +17,458 | New |
| UBS Group AG | 8,017 | $2.33K | 0.00% | +6,366+385.6% | Added |
| Tower Research Capital LLC (TRC) | 7,338 | $2.14K | 0.00% | −24−0.3% | Reduced |
| Advisor Group Holdings, Inc. | 3,600 | $1.05K | 0.00% | −15,150−80.8% | Reduced |
| Morgan Stanley | 2,292 | $668 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 652 | $190 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 85 | $25 | 0.00% | −11−11.5% | Reduced |
| JPMorgan Chase & Co | 13 | $4 | 0.00% | +13 | New |
| Lake Street Advisors Group, LLC | 316,469 | $0 | 0.00% | 00.0% | Unchanged |